Search
for
Sort by
Research 421–450 of 1000+
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Finasteride in the Treatment of Hirsutism
- Spironolactone in dermatology: uses in acne and beyond
- Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
- Postmenopausal Alopecia (Hair Loss)
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare
- A review on follicular targeting for the treatment of hirsutism
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Natural progression of male pattern baldness in young men
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Hormone therapy in acne
- Managing polycystic ovary syndrome in primary care
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Treatment of idiopathic facial hirsutism with medroxyprogesterone acetate iontophoresis
- The Effect of Finasteride on Serum Cortisol and testosterone Levels in Rats
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- Androgens in SARS-CoV-2 Coronavirus Infections
- Effect of Latanoprost on Hair Growth in the Bald Scalp of the Stump-tailed Macacque: A Pilot Study
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Drug repositioning using <i>in silico</i> compound profiling
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Optimized Nanostructured Lipid Carriers for Dutasteride Delivery: Improving Therapeutic Efficiency and Minimizing Adverse Effects
- Arecaceae
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome